| dc.contributor.author | Genç, Murat | |
| dc.contributor.author | Karagoz Genc, Zuhal | |
| dc.contributor.author | Tekin, Suat | |
| dc.contributor.author | Sandal, Süleyman | |
| dc.contributor.author | Sirajuddin, Muhammad | |
| dc.contributor.author | Ben Hadda, Taibi | |
| dc.contributor.author | Şekerci, Memet | |
| dc.date.accessioned | 2023-06-05T05:33:41Z | |
| dc.date.available | 2023-06-05T05:33:41Z | |
| dc.date.issued | 2016 | |
| dc.identifier.issn | 1318-0207 | |
| dc.identifier.uri | http://dspace.adiyaman.edu.tr:8080/xmlui/handle/20.500.12414/4526 | |
| dc.description.abstract | This article demonstrates the synthesis of 1,2,4-triazole derivatives and their applications in medicine particularly as anti-breast cancer agents which is a major issue of the present. The synthesized compounds were characterized by elemental analysis, FT-IR and NMR. DFT was used to study the quantum chemical calculations of geometries and vibrational wave numbers of 3-hydroxynaphthyl and p-tolyl substituted 1,2,4-triazoles in the ground state. The scaled harmonic vibrational frequencies obtained from the DFT method were compared with those of the FT-IR spectra and found good agreement. The synthesized 1,2,4-triazole-naphthyl hybrids were screened for the anticancer activity against MCF-7 breast cancer lines. Among them compounds 3 and 7 showed broad spectrum anticancer activity with IC50 values 9.7 mu M and 7.10 mu M, respectively and their activity is comparable to that of the standard drugs. The molecular model for binding between the compounds (1-8) and the active site of BRCA2 was obtained on the basis of the computational docking results and the structure-activity relationship. | tr | 
| dc.language.iso | en | tr | 
| dc.publisher | Slovensko Kemıjsko Drustvo | tr | 
| dc.subject | 1,2,4-triazoles | tr | 
| dc.subject | Docking | tr | 
| dc.subject | DFT | tr | 
| dc.subject | POM Analysis | tr | 
| dc.subject | Breast cancer | tr | 
| dc.title | Design, Synthesis, in vitro Antiproliferative Activity, Binding Modeling of 1,2,4,-Triazoles as New Anti-Breast Cancer Agents | tr | 
| dc.type | Article | tr | 
| dc.contributor.authorID | 0000-0003-1224-4128 | tr | 
| dc.contributor.authorID | 000-0002-2757-1802 | tr | 
| dc.contributor.authorID | 0000-0002-8916-3329 | tr | 
| dc.contributor.authorID | 0000-0002-1147-1284 | tr | 
| dc.contributor.authorID | 0000-0002-5633-6203 | tr | 
| dc.contributor.authorID | 0000-0002-7730-645X | tr | 
| dc.contributor.department | Adiyaman Univ, Fac Sci & Arts, Dept Chem, | tr | 
| dc.contributor.department | Adiyaman Univ, Fac Engn, Dept Mat & Met Engn, | tr | 
| dc.contributor.department | Inonu Univ, Fac Med, Dept Physiol, | tr | 
| dc.contributor.department | COMSATS Inst Informat Technol, Dept Chem | tr | 
| dc.contributor.department | Univ Mohammed IER, Lab Chim Mat | tr | 
| dc.contributor.department | Firat Univ, Dept Chem, Fac Sci, | tr | 
| dc.identifier.endpage | 737 | tr | 
| dc.identifier.issue | 4 | tr | 
| dc.identifier.startpage | 726 | tr | 
| dc.identifier.volume | 63 | tr | 
| dc.source.title | Acta Chımıca Slovenıca | tr |